August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
ASCO 2025 Science in Seconds: Charu Aggarwal on How a Molecular Assay May Help Identify People with NSCLC
Jun 1, 2025, 07:55

ASCO 2025 Science in Seconds: Charu Aggarwal on How a Molecular Assay May Help Identify People with NSCLC

American Society of Clinical Oncology (ASCO) shared a post on LinkedIn:

“Check out our ASCO 25 Science in Seconds!
Dr. Charu Aggarwal discusses how a molecular assay may help identify people with NSCLC who could benefit from adj. chemotherapy.
Learn more.”

Title: An international, multicenter, prospective randomized trial of adjuvant chemotherapy for stage Ia-IIa non-small cell lung cancer identified as high-risk by a 14-gene molecular assay

Journal: ASCO, Journal of Clinical Oncology

Authors: David Spigel, Virginie Westeel, Ian Anderson, Laurent Greillier, Florian Guisier, Olivier Bylicki, Firas Badin, Gaelle Rousseau-Bussac, Clotilde Deldycke, Frank Griesinger, Adam Bograd, Wangjian Zhong, Matthew Gubens, John Crowley, Heiko von der Leyen, Gavitt Woodard, Johannes Kratz, David Jablons, Michael Mann

Read the full abstract.

Charu Aggarwal

More posts featuring Charu Aggarwal on OncoDaily.